Rare DNA mutations, now detectable by NanoSeq, could reframe autoimmune disease management

Rare DNA mutations, now detectable by NanoSeq, could reframe autoimmune disease management. For Indian pharma & diagnostics, this signals a major pivot towards precision medicine and early detection.

Think targeted therapies, not just broad immunosuppressants. Huge for biotech R&D and new diagnostic kits tailored for our diverse patient base.

https://health.economictimes.indiatimes.com/news/industry/dna-mutations-in-immune-cells-could-be-driving-autoimmune-diseases-study-suggests/130295873